BIOMAT Database Logo BIOMAT Database Logo

Synthesis and anti-HIV evaluation of 2',3'-dideoxyribo-5-chloropyrimidine analogues: reduced toxicity of 5-chlorinated 2',3'-dideoxynucleosides. 1990

A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Laboratories of Pharmaceutical Chemistry, Rega Institute for Medical Research, Leuven, Belgium.

In view of the selective anti-HIV activity of 2',3'-dideoxy-3'-fluoro-5-chlorouridine (11), a series of eight 2',3'-dideoxy-5-chloropyrimidines were synthesized and evaluated for their inhibitory activity against human immunodeficiency virus type 1 (HIV-1) replication in MT-4 cells. A marked improvement in selectivity was noted for the 5-chlorouracil derivatives of 2,3-dideoxyribofuranose, 3-azido-2,3-dideoxyribofuranose, and 3-fluoro-2,3-dideoxyribofuranose, mainly due to decreased toxicity of the compounds for the host cells. While chlorination of 2',3'-dideoxycytidine removed the anti-HIV activity, introduction of a chlorine at the C-5 position of 3'-fluoro-, 3'-azido- or 2',3'-didehydro-2',3'-dideoxycytidine led to reduced cytotoxicity with only slightly reduced anti-HIV activity. X-ray analysis showed compound 11 to have two molecules in the asymmetric unit with chi = -168.8 (3) degrees and -131.3 (3) degrees and P = 179 (1) degree and 163 (1) degree, respectively; thus revealing no close resemblance to 3'-azido-3'-deoxythymidine (AZT).

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides

Related Publications

A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
5'-O-phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity.
September 1990, Journal of medicinal chemistry,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Synthesis of isoxazolidino analogues of 2',3'-dideoxynucleosides.
January 1999, Nucleosides & nucleotides,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Synthesis and anti-HIV activity of 4'-thio-2',3'-dideoxynucleosides.
February 1992, Journal of medicinal chemistry,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Synthesis of 3'-(4-nitroimidazol-1-yl)-2',3'-dideoxynucleosides of pyrimidine analogues and their biological evaluation against HIV.
December 1990, Archiv der Pharmazie,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotides.
March 2000, Antiviral research,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Stannylation approach to the synthesis of 2'- and 3'-substituted analogues of 2',3'-didehydro-2',3'-dideoxynucleosides.
January 2003, Nucleosides, nucleotides & nucleic acids,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2',3'-seco-3'-nor DCP and DCK analogues.
October 2011, European journal of medicinal chemistry,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
New synthesis of 2',3'-didehydro-2',3'-dideoxynucleosides.
November 1991, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Synthesis of 2'- 3'-carbon-substituted 2',3'-didehydro-2',3'-dideoxynucleosides.
January 1991, Nucleic acids symposium series,
A Van Aerschot, and D Everaert, and J Balzarini, and K Augustyns, and L Jie, and G Janssen, and O Peeters, and N Blaton, and C De Ranter, and E De Clercq
Stereospecific synthesis and antiviral activities of beta-L-2',3'-dideoxy-5-chloropyrimidine nucleoside derivatives.
January 1999, Nucleosides & nucleotides,
Copied contents to your clipboard!